Australian Biotech Stock News

LDR Capital Property Fund is trading like a problem child. The stock has fallen about 20% over the past week and sits at A$0.43, even as this result puts the real issue front and centre. The headline is not earnings per share; it is the pressure between generous historic distributions and the cash actually left after funding the portfolio. Funds from operations in the year and the much thinner adjusted funds from operations line show why management is resetting payouts and tackling debt. For...

ReadyTech Holdings stock came into today under a cloud, with the share price down about 5% over the past month even after a stronger 90 day run. The headline from these full year numbers is margin pressure in a business still chasing profitability. Underlying cash EBITDA sat at A$15.8m on A$125m of revenue, while reported earnings from continuing operations were a loss of A$4.9m over the trailing twelve months. Looking for profitable growth stocks with fewer margin questions than ReadyTech...

Magellan Financial Group closed at A$9.05 after a tough week that left the stock down roughly 14% over seven days and slightly weaker over the month. The market is clearly focused on pressure rather than promise. The headline from these full year results is the squeeze on the core investment management engine as fee revenue and earnings feel the impact of heavy fund outflows and lower average fee rates. In the short term, that profit compression is what traders are reacting to. In the longer...

Mesoblast Limited has reported full-year 2026 results showing revenue of US$120.25 million versus US$17.2 million a year earlier, with its net loss reduced to US$57.5 million from US$102.14 million and loss per share almost halved. Alongside RYONCIL’s first full year of commercial sales, Mesoblast has completed patient treatment in a pivotal Phase 3 trial of rexlemestrocel-L for chronic low back pain, underscoring its dual focus on near-term revenue and late-stage pipeline assets. Now, we’ll...

South32 has delivered strong share price returns over the past five years, yet the current share price of A$5.21 sits well below one widely used intrinsic value estimate. For investors, that raises the question of whether the recent strength has already captured the stock's fundamentals or whether there is still a margin between price and estimated value. South32 has returned 98.5% over the past five years, which puts recent gains into focus when weighing what the current valuation may...

What Worley’s latest earnings and dividend announcement mean for investors Worley (ASX:WOR) recently combined its full year 2026 earnings release with confirmation of a final dividend, giving investors fresh information on both profitability and cash returns. The company reported revenue of A$10,714 million for the year to 30 June 2026, with net income of A$238 million. Management also highlighted 2.3% constant currency revenue growth and progress on cost savings targets. At the same time,...

Eurozone private sector credit growth has reached a three year high, which signals banks are more willing to fund households and businesses again. That kind of credit pulse often lines up with stronger earnings potential for companies that can turn fresh financing into growth. This article walks through three stocks from the Healthy high growth potential screener that analysts expect to benefit from improving credit conditions. The three stocks that follow are just a small sample, and the...

The Australian market is showing mixed signals, with the S&P/ASX 200 expected to open steady despite recent declines and ongoing concerns about interest rates and final earnings reports. In this context, investors often look for opportunities that balance risk with potential growth, which is where penny stocks come into play. Although the term "penny stocks" might seem outdated, these smaller or newer companies can offer significant growth potential when supported by strong financials and...

With core inflation stuck at 3.6% and talk of a possible cash rate hike at the next RBA meeting, higher borrowing costs are back in focus and so are the Australian banks and financial stocks most exposed to this news. This period could reward investors who understand which lenders might benefit from firmer margins. In this article you will see 3 stocks from the screener that appear positioned to respond positively to this backdrop. The three stocks in this article are just a starting sample...

As you might know, Woolworths Group Limited ( ASX:WOW ) recently reported its yearly numbers. The result was positive...

Those following along with Orion Minerals Limited ( ASX:ORN ) will no doubt be intrigued by the recent purchase of...

Potential Servcorp Limited ( ASX:SRV ) shareholders may wish to note that the Founder, Alfred Moufarrige, recently...

We feel now is a pretty good time to analyse Ai-Media Technologies Limited's ( ASX:AIM ) business as it appears the...

Even if it's not a huge purchase, we think it was good to see that Nicholas Pagent, the CEO & Executive Director of...

Some PWR Holdings Limited ( ASX:PWH ) shareholders may be a little concerned to see that the Chief Technical and...

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Some Origin Energy Limited ( ASX:ORG ) shareholders may be a little concerned to see that the MD, CEO & Executive...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

As the Australian market grapples with the implications of recent Consumer Price Index figures, which saw a 3.5% rise over the past year, concerns about potential interest rate adjustments are at the forefront of investor considerations. In this environment, dividend stocks can offer stability and income potential, making them an attractive option for those looking to navigate uncertain economic conditions while benefiting from regular cash returns.

As the Australian market reacts to the latest Consumer Price Index numbers, concerns about rising interest rates are at the forefront of investors' minds, with a slight forecasted dip in the ASX reflecting these pressures. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business and may provide resilience amidst economic uncertainties.

As the Australian market navigates the implications of rising Consumer Price Index numbers and potential interest rate pressures, investors are keeping a close eye on undervalued opportunities amid these economic shifts. Identifying stocks that are trading below their intrinsic value can be a strategic move, especially in times when market conditions present both challenges and opportunities for discerning investors.

The Australian market is experiencing a slight downturn as it processes the latest Consumer Price Index numbers, which have raised concerns about potential interest rate pressures. Despite these challenges, certain sectors continue to offer intriguing opportunities for investors. Penny stocks, though often considered a term from bygone trading days, remain relevant by offering growth potential at lower price points. These smaller or newer companies can provide significant upside when backed...

Sonic Healthcare Limited has released its full-year results for the year ended June 30, 2026, reporting revenue of A$10.97 billion, net income of A$608.29 million and declaring a semi-annual dividend of A$0.63 per share, payable on September 17, 2026. The combination of higher sales and earnings compared with the prior year and the confirmed dividend suggests the company is emphasizing both growth and ongoing cash returns to shareholders. Now we will examine how this higher full-year revenue...

BCI Minerals has released its full-year results for the period ended June 30, 2026, reporting revenue of A$6.2 million and net income of A$30.8 million, compared with revenue of A$5.8 million and a net loss of A$47 million in the prior year. The sharp swing from loss to profit, achieved on only modestly higher revenue, points to materially improved cost control, project accounting, or one-off gains that could reshape how investors assess the business. We’ll now examine how this move to...